Literature DB >> 20809113

Demographic differences in incidence for pituitary adenoma.

Bradley D McDowell1, Robert B Wallace, Ryan M Carnahan, Elizabeth A Chrischilles, Charles F Lynch, Janet A Schlechte.   

Abstract

Incidence estimates for pituitary adenomas vary widely, suggesting the effects of numerous risk factors or varying levels of tumor surveillance. We studied the epidemiology of pituitary adenomas using 2004-2007 data collected by 17 Surveillance, Epidemiology, and End Results Programs in the United States (N = 8,276). We observed that incidence rates generally increased with age and were higher in females in early life and higher in males in later life. Males are diagnosed with larger tumors on average than females. Diagnosis may be delayed for males, giving tumors a chance to grow larger before clinical detection. We also observed that American Blacks have higher incidence rates for pituitary adenomas compared with other ethnic groups. There are several potential explanations for this finding with some evidence that at least part of the effect may be due to differential diagnosis between races.

Entities:  

Mesh:

Year:  2011        PMID: 20809113      PMCID: PMC3652258          DOI: 10.1007/s11102-010-0253-4

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  16 in total

1.  Racial differences in the treatment of early-stage lung cancer.

Authors:  P B Bach; L D Cramer; J L Warren; C B Begg
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

Review 2.  Pituitary prolactinomas.

Authors:  J D Nabarro
Journal:  Clin Endocrinol (Oxf)       Date:  1982-08       Impact factor: 3.478

3.  Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Thomas Thom; Nancy Haase; Wayne Rosamond; Virginia J Howard; John Rumsfeld; Teri Manolio; Zhi-Jie Zheng; Katherine Flegal; Christopher O'Donnell; Steven Kittner; Donald Lloyd-Jones; David C Goff; Yuling Hong; Robert Adams; Gary Friday; Karen Furie; Philip Gorelick; Brett Kissela; John Marler; James Meigs; Veronique Roger; Stephen Sidney; Paul Sorlie; Julia Steinberger; Sylvia Wasserthiel-Smoller; Matthew Wilson; Philip Wolf
Journal:  Circulation       Date:  2006-01-11       Impact factor: 29.690

Review 4.  Mechanisms for pituitary tumorigenesis: the plastic pituitary.

Authors:  Shlomo Melmed
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

5.  Residual treatment disparities after oncology referral for rectal cancer.

Authors:  Arden M Morris; Kevin G Billingsley; Awori J Hayanga; Barbara Matthews; Laura-Mae Baldwin; John D Birkmeyer
Journal:  J Natl Cancer Inst       Date:  2008-05-13       Impact factor: 13.506

6.  Incidence and familial risks in pituitary adenoma and associated tumors.

Authors:  Kari Hemminki; Asta Försti; Jianguang Ji
Journal:  Endocr Relat Cancer       Date:  2007-03       Impact factor: 5.678

7.  The trends in incidence of primary brain tumors in the population of Rochester, Minnesota.

Authors:  K Radhakrishnan; B Mokri; J E Parisi; W M O'Fallon; J Sunku; L T Kurland
Journal:  Ann Neurol       Date:  1995-01       Impact factor: 10.422

8.  The ethnic distribution of primary central nervous system tumors: AFIP, 1958 to 1970.

Authors:  K J Fan; J Kovi; K M Earle
Journal:  J Neuropathol Exp Neurol       Date:  1977-01       Impact factor: 3.685

9.  Prevalence and presentation of hyperprolactinaemia in patients with "functionless" pituitary tumours.

Authors:  S Franks; J D Nabarro
Journal:  Lancet       Date:  1977-04-09       Impact factor: 79.321

10.  Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics?

Authors:  Elana Curtis; Chris Quale; David Haggstrom; Rebecca Smith-Bindman
Journal:  Cancer       Date:  2008-01-01       Impact factor: 6.860

View more
  32 in total

1.  Role of a p53 polymorphism in the development of nonfunctional pituitary adenomas.

Authors:  Garima Yagnik; Arman Jahangiri; Rebecca Chen; Jeffrey R Wagner; Manish K Aghi
Journal:  Mol Cell Endocrinol       Date:  2017-02-16       Impact factor: 4.102

2.  Vestibular schwannoma and pituitary adenoma in the same patient: coincidence or novel clinical association?

Authors:  Matthew L Carlson; Neil S Patel; Amy E Glasgow; Elizabeth B Habermann; Brandon R Grossardt; Michael J Link
Journal:  J Neurooncol       Date:  2016-02-22       Impact factor: 4.130

3.  Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas.

Authors:  Henriett Butz; Kinga Németh; Dóra Czenke; István Likó; Sándor Czirják; Vladimir Zivkovic; Kornélia Baghy; Márta Korbonits; Ilona Kovalszky; Péter Igaz; Károly Rácz; Attila Patócs
Journal:  Pathol Oncol Res       Date:  2016-12-21       Impact factor: 3.201

4.  Pituitary adenomas in elderly patients: clinical and surgical outcome analysis in a large series.

Authors:  Alfio Spina; Marco Losa; Pietro Mortini
Journal:  Endocrine       Date:  2019-06-17       Impact factor: 3.633

5.  Expression of cell growth negative regulators MEG3 and GADD45γ is lost in most sporadic human pituitary adenomas.

Authors:  Lisiane Cervieri Mezzomo; Paulo Henrique Gonzales; Frederico Giacomoni Pesce; Nélson Kretzmann Filho; Nelson Pires Ferreira; Miriam Costa Oliveira; Maria Beatriz Fonte Kohek
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

Review 6.  Epidemiology and etiopathogenesis of pituitary adenomas.

Authors:  Elena D Aflorei; Márta Korbonits
Journal:  J Neurooncol       Date:  2014-01-31       Impact factor: 4.130

7.  A Review of Skull Base Tumor Clinical Trials: Past Trends and Future Opportunities.

Authors:  Anand Devaiah; Charles Murchison
Journal:  J Neurol Surg B Skull Base       Date:  2016-08-24

8.  Gamma Knife radiosurgery as the initial treatment for elderly patients with nonfunctioning pituitary adenomas.

Authors:  Lifeng Zhang; Wei Chen; Chang Ding; Yanjia Hu; Yuan Tian; Huiyang Luo; Jing Chen
Journal:  J Neurooncol       Date:  2021-02-27       Impact factor: 4.130

9.  Non-functioning pituitary macroadenomas: factors affecting postoperative recurrence, and pre- and post-surgical endocrine and visual function.

Authors:  Venkatram Subramanian; Rachel Su Min Lee; Simon Howell; Samuel Gregson; Ian M Lahart; Kalpana Kaushal; Joseph M Pappachan
Journal:  Endocrine       Date:  2021-04-06       Impact factor: 3.633

10.  Clinical outcomes in male patients with lactotroph adenomas who required pituitary surgery: a retrospective single center study.

Authors:  Winnie Liu; Roula Shraiky Zahr; Shirley McCartney; Justin S Cetas; Aclan Dogan; Maria Fleseriu
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.